Apolipoprotein M Protects Against Lipopolysaccharide-Induced Acute Lung Injury via Sphingosine-1-Phosphate Signaling

[1]  G. Luo,et al.  Decreased Splenic CD4+ T-Lymphocytes in Apolipoprotein M Gene Deficient Mice , 2015, BioMed research international.

[2]  I. Velasco,et al.  Hypertonic Saline (NaCl 7.5 %) Reduces LPS-Induced Acute Lung Injury in Rats , 2015, Inflammation.

[3]  Zhijie He,et al.  Toll-like receptor 4 monoclonal antibody attenuates lipopolysaccharide-induced acute lung injury in mice , 2014, Experimental and therapeutic medicine.

[4]  W. Zin,et al.  Redox markers and inflammation are differentially affected by atorvastatin, pravastatin or simvastatin administered before endotoxin-induced acute lung injury. , 2013, International immunopharmacology.

[5]  C. Christoffersen,et al.  Apolipoprotein M: bridging HDL and endothelial function , 2013, Current opinion in lipidology.

[6]  S. Parikh.  Dysregulation of the angiopoietin–Tie-2 axis in sepsis and ARDS , 2013, Virulence.

[7]  Ó. Peñuelas,et al.  Comparison of the Berlin definition for acute respiratory distress syndrome with autopsy. , 2013, American journal of respiratory and critical care medicine.

[8]  C. Sprung,et al.  Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012 , 2013, Intensive Care Medicine.

[9]  H. Qiu,et al.  Kinetic and distinct distribution of conventional dendritic cells in the early phase of lipopolysaccharide-induced acute lung injury , 2012, Molecular Biology Reports.

[10]  J. French,et al.  Infection and inflammation , 2012, BMC Pregnancy and Childbirth.

[11]  Arthur S Slutsky,et al.  Acute Respiratory Distress Syndrome The Berlin Definition , 2012 .

[12]  Adam Linder,et al.  Decreased plasma concentrations of apolipoprotein M in sepsis and systemic inflammatory response syndromes , 2012, Critical Care.

[13]  G. Nieman,et al.  Jack of all trades: pleiotropy and the application of chemically modified tetracycline-3 in sepsis and the acute respiratory distress syndrome (ARDS). , 2011, Pharmacological research.

[14]  T. Hla,et al.  Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors. , 2011, Chemical reviews.

[15]  J. Garcia,et al.  Protection of LPS-induced murine acute lung injury by sphingosine-1-phosphate lyase suppression. , 2011, American journal of respiratory cell and molecular biology.

[16]  B. Dahlbäck,et al.  Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M , 2011, Proceedings of the National Academy of Sciences.

[17]  C. Bai,et al.  The value of the lipopolysaccharide-induced acute lung injury model in respiratory medicine , 2010, Expert review of respiratory medicine.

[18]  J. Garcia,et al.  Differential effects of sphingosine 1-phosphate receptors on airway and vascular barrier function in the murine lung. , 2010, American journal of respiratory cell and molecular biology.

[19]  P. Nilsson-ehle,et al.  Expression and localization of apolipoprotein M in human colorectal tissues , 2010, Lipids in Health and Disease.

[20]  T. Matsuo,et al.  Lipoproteins and CETP levels as risk factors for severe sepsis in hospitalized patients , 2010, European journal of clinical investigation.

[21]  G. Schmitz,et al.  Changes in HDL-associated apolipoproteins relate to mortality in human sepsis and correlate to monocyte and platelet activation , 2009, Intensive Care Medicine.

[22]  S. Coughlin,et al.  Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. , 2009, The Journal of clinical investigation.

[23]  L. Badimón,et al.  Sphingosine-1-phosphate: A bioactive lipid that confers high-density lipoprotein with vasculoprotection mediated by nitric oxide and prostacyclin , 2009, Thrombosis and Haemostasis.

[24]  K. Syrjänen,et al.  Up-regulation of VEGF, c-fms and COX-2 expression correlates with severity of cervical cancer precursor (CIN) lesions and invasive disease. , 2008, Gynecologic oncology.

[25]  K. Feingold,et al.  Infection and inflammation decrease apolipoprotein M expression. , 2008, Atherosclerosis.

[26]  J. Romijn,et al.  Plasma apolipoprotein CI correlates with increased survival in patients with severe sepsis , 2008, Intensive Care Medicine.

[27]  M. Levy,et al.  Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 , 2007, Intensive Care Medicine.

[28]  C. Bai,et al.  Airway epithelial dysfunction in the development of acute lung injury and acute respiratory distress syndrome , 2007, Expert review of respiratory medicine.

[29]  K. Pritchard,et al.  ENDOTHELIUM-DERIVED MICROPARTICLES INDUCE ENDOTHELIAL DYSFUNCTION AND ACUTE LUNG INJURY , 2006, Shock.

[30]  Liduan Zheng,et al.  Upregulation of hypoxia‐induced mitogenic factor in bacterial lipopolysaccharide‐induced acute lung injury , 2006, FEBS letters.

[31]  Diane P. Martin,et al.  Incidence and outcomes of acute lung injury. , 2005, The New England journal of medicine.

[32]  M. Ochs,et al.  Inhalative pre-treatment of donor lungs using the aerosolized prostacyclin analog iloprost ameliorates reperfusion injury. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[33]  Pan‐Chyr Yang,et al.  Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis* , 2005, Critical care medicine.

[34]  J. Hazelzet,et al.  Serum lipids and disease severity in children with severe meningococcal sepsis* , 2005, Critical care medicine.

[35]  E. Goetzl,et al.  Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network , 2005, Nature Reviews Immunology.

[36]  Thomas E Stewart,et al.  Development of a clinical definition for acute respiratory distress syndrome using the Delphi technique. , 2005, Journal of critical care.

[37]  J. Chun,et al.  Cell surface receptors in lysophospholipid signaling. , 2004, Seminars in cell & developmental biology.

[38]  Kenneth R Feingold,et al.  Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. , 2004, Journal of lipid research.

[39]  J. Dayer,et al.  Low apolipoprotein A-I level at intensive care unit admission and systemic inflammatory response syndrome exacerbation* , 2004, Critical care medicine.

[40]  R. Hotchkiss,et al.  The pathophysiology and treatment of sepsis. , 2003, The New England journal of medicine.

[41]  Jonathan Cohen.  The immunopathogenesis of sepsis , 2002, Nature.

[42]  D. Im,et al.  Characterization of a zebrafish (Danio rerio) sphingosine 1-phosphate receptor expressed in the embryonic brain. , 2000, Biochemical and biophysical research communications.

[43]  S. Pyne,et al.  Sphingosine 1-phosphate signalling via the endothelial differentiation gene family of G-protein-coupled receptors. , 2000, Pharmacology & therapeutics.

[44]  C. H. Liu,et al.  Sphingosine‐1‐Phosphate Signaling via the EDG‐1 Family of G‐Protein‐Coupled Receptors , 2000, Annals of the New York Academy of Sciences.

[45]  B. Dahlbäck,et al.  A Novel Human Apolipoprotein (apoM)* , 1999, The Journal of Biological Chemistry.

[46]  A. Rotta,et al.  Partial liquid ventilation reduces pulmonary neutrophil accumulation in an experimental model of systemic endotoxemia and acute lung injury. , 1998, Critical care medicine.

[47]  J. Connett,et al.  Prolonged partial liquid ventilation using conventional and high-frequency ventilatory techniques: gas exchange and lung pathology in an animal model of respiratory distress syndrome. , 1997, Critical care medicine.

[48]  A. Nahum,et al.  Effect of mechanical ventilation strategy on dissemination of intratracheally instilled Escherichia coli in dogs. , 1997, Critical care medicine.

[49]  T. Miyamoto,et al.  Rudimentary Meningocele of the Scalp , 1997, The Journal of dermatology.

[50]  R. H. Smith,et al.  A murine model of pulmonary damage induced by lipopolysaccharide via intranasal instillation. , 1997, Journal of immunological methods.

[51]  G. Zimmerman,et al.  The acute respiratory distress syndrome. , 1996, The Journal of clinical investigation.

[52]  M. Lamy,et al.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. , 1994, American journal of respiratory and critical care medicine.

[53]  A. Katzenstein,et al.  Diffuse alveolar damage--the role of oxygen, shock, and related factors. A review. , 1976, The American journal of pathology.

[54]  E. Seeley,et al.  Increased expression of neutrophil-related genes in patients with early sepsis-induced ARDS. , 2015, American journal of physiology. Lung cellular and molecular physiology.

[55]  W. Kuebler,et al.  Role of L-selectin in leukocyte sequestration in lung capillaries in a rabbit model of endotoxemia. , 2000, American journal of respiratory and critical care medicine.

[56]  S. Kunkel,et al.  New Frontiers in Cytokine Involvement during Experimental Sepsis. , 1999, ILAR journal.